Maximizing Outcomes in Relapsed/Refractory Multiple Myeloma: Tailoring Bispecific Antibody Approaches

home / meeting-of-the-minds / maximizing-outcomes-in-relapsed-refractory-multiple-myeloma-tailoring-bispecific-antibody

The "Maximizing Outcomes in Relapsed/Refractory Multiple Myeloma: Tailoring Bispecific Antibody Approaches" video series explores tailored treatment strategies for patients with relapsed/refractory multiple myeloma using bispecific antibodies, featuring expert insights and a patient profile portrayal to guide clinical decision-making.

© 2024 MJH Life Sciences

All rights reserved.